BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24829855)

  • 1. Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB.
    Minig L; Patrono MG; Romero N; Rodríguez Moreno JF; Garcia-Donas J
    World J Clin Oncol; 2014 May; 5(2):86-92. PubMed ID: 24829855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative treatments for stage IB-IIB uterine cervical cancer.
    Shimada M; Tokunaga H; Kobayashi H; Ishikawa M; Yaegashi N
    Jpn J Clin Oncol; 2020 Feb; 50(2):99-103. PubMed ID: 31868879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
    Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J
    Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
    Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
    Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
    Benedetti-Panici P; Greggi S; Scambia G; Amoroso M; Salerno MG; Maneschi F; Cutillo G; Paratore MP; Scorpiglione N; Mancuso S
    Eur J Cancer; 1998 Feb; 34(3):341-6. PubMed ID: 9640219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
    Uegaki K; Shimada M; Sato S; Deura I; Naniwa J; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
    Int J Clin Oncol; 2014 Apr; 19(2):348-53. PubMed ID: 23592280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
    Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
    J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
    Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
    Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic versus open radical hysterectomy for stage IB2-IIB cervical cancer in the setting of neoadjuvant chemotherapy: a multi-institutional cohort study.
    Ghezzi F; Cromi A; Ditto A; Vizza E; Malzoni M; Raspagliesi F; Uccella S; Corrado G; Cosentino F; Gotsch F; Martinelli F; Franchi M
    Ann Surg Oncol; 2013 Jun; 20(6):2007-15. PubMed ID: 23224830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (Bulky Tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group.
    Mikami M; Aoki Y; Sakamoto M; Shimada M; Takeshima N; Fujiwara H; Matsumoto T; Kita T; Takizawa K;
    Int J Gynecol Cancer; 2014 Sep; 24(7):1333-40. PubMed ID: 25078340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
    Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K
    Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.